Larotrectinib in a NTRK‐rearranged soft tissue sarcoma in the neoadjuvant setting: A case report

Patients with soft tissue sarcomas should be assessed for neurotrophic tropomyosin receptor kinase (NTRK) gene fusions as neoadjuvant treatment with larotrectinib may prevent amputation.

Detalles Bibliográficos
Autores principales: Percy, Catherine, Schubert, Thomas, Galant, Christine, Kirchgesner, Thomas, Mazzeo, Filomena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981750/
https://www.ncbi.nlm.nih.gov/pubmed/33768917
http://dx.doi.org/10.1002/ccr3.3878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981750/
https://www.ncbi.nlm.nih.gov/pubmed/33768917
http://dx.doi.org/10.1002/ccr3.3878

Ejemplares similares